Disease 指定難病
疾患数 : 338 - 臨床試験総数 : 33,695 / 薬物総数 : 21,110 - ( DrugBank : 2,155 ) / 標的遺伝子総数 : 623 - 標的パスウェイ総数 : 291
疾患群: 呼吸器系疾患Showing 1 to 10 of 14 diseases
告示 番号 | 疾患名 [疾患群] | 臨床試験数 Phase 1 / 2 / 3 / 4 | 薬物数 [ DrugBank ] | 標的遺伝子数 パスウェイ数 | 国内患者数 - (1) 概要、診断基準等, (2) 医療費受給者証所持者数 (2021年度) |
---|---|---|---|---|---|
84 | サルコイドーシス [呼] 💬 "Sarcoidosis" | 149 149 trials 53 / 64 / 30 / 26 💬 | 227 227 drugs [ 81 81 drugs ] | 82 82 genes 167 pathways | 15655 (1) 26,763人 (2) 15,655人 年齢分布 ![]() |
85 | 特発性間質性肺炎 [呼] 💬 "Idiopathic interstitial pneumonia", "IIPs", "Idiopathic pulmonary fibrosis", "IPF", "Usual interstitial pneumonia", "UIP", "Non-specific interstitial pneumonia", "NSIP", "Acute interstitial pneumonia", "AIP", "Diffuse alveolar damage", "DAD", "Cryptogenic organizing pneumonia", "COP", "Organizing pneumonia", "OP", "Desquamative interstitial pneumonia", "DIP", "Respiratory bronchiolitis - associated interstitial lung disease", "RB-ILD", "Lymphocytic interstitial pneumonia", "LIP" "Idiopathic interstitial pneumonia", "IIPs", "Idiopathic pulmonary fibrosis", "IPF", "Usual intersti ... | 598 598 trials 211 / 235 / 160 / 60 💬 | 435 435 drugs [ 116 116 drugs ] | 100 100 genes 210 pathways | 17665 (1) 約 15,000人以上(平成26年度医療受給者証保持者数;8,846人) (2) 17,665人 年齢分布 ![]() |
86 | 肺動脈性肺高血圧症 [呼] 💬 "Pulmonary arterial hypertension", "PAH", "IPAH", "HPAH", "Eisenmenger syndrome" | 1,181 1,181 trials 419 / 302 / 467 / 174 💬 | 701 701 drugs [ 126 126 drugs ] | 105 105 genes 192 pathways | 4319 (1) 2,299人 (2) 4,319人 年齢分布 ![]() |
87 | 肺静脈閉塞症/肺毛細血管腫症 [呼] 💬 "Pulmonary veno-occlusive disease", "Pulmonary capillary hemangiomatosis", "PVOD", "PCH" | 3 3 trials 1 / 1 / 0 / 0 💬 | 4 4 drugs [ 3 3 drugs ] | 4 4 genes 45 pathways | 24 (1) 約100人 (2) 24人 年齢分布 ![]() |
88 | 慢性血栓塞栓性肺高血圧症 [呼] 💬 "Chronic thromboembolic pulmonary hypertension", "CTEPH", "Idiopathic chronic pulmonary thromboembolism" "Chronic thromboembolic pulmonary hypertension", "CTEPH", "Idiopathic chronic pulmonary thromboembol ... | 159 159 trials 82 / 51 / 70 / 19 💬 | 118 118 drugs [ 23 23 drugs ] | 13 13 genes 53 pathways | 4843 (1) 1,810人 (2) 4,843人 年齢分布 ![]() |
89 | リンパ脈管筋腫症 [呼] 💬 "Lymphangioleiomyomatosis", "LAM", "Sporadic lymphangioleiomyomatosis", "Sporadic LAM", "Lymphangioleiomyomatosis with tuberous sclerosis", "TSC-LAM" "Lymphangioleiomyomatosis", "LAM", "Sporadic lymphangioleiomyomatosis", "Sporadic LAM", "Lymphangiol ... | 39 39 trials 15 / 18 / 8 / 2 💬 | 46 46 drugs [ 20 20 drugs ] | 27 27 genes 137 pathways | 912 (1) 689人 (2) 912人 年齢分布 ![]() |
228 | 閉塞性細気管支炎 [呼] 💬 "Bronchiolitis obliterans", "Obliterating bronchiolitis" | 96 96 trials 49 / 38 / 35 / 16 💬 | 125 125 drugs [ 34 34 drugs ] | 33 33 genes 155 pathways | 35 (1) 約300〜500人 (2) 35人 年齢分布 ![]() |
229 | 肺胞蛋白症(自己免疫性又は先天性) [呼] 💬 "Autoimmune pulmonary alveolar proteinosis", "Congenital pulmonary alveolar proteinosis", "Hereditary pulmonary alveolar proteinosis", "Pulmonary alveolar proteinosis", "PAP", "Autoimmune PAP", "Congenital PAP" "Autoimmune pulmonary alveolar proteinosis", "Congenital pulmonary alveolar proteinosis", "Hereditar ... | 43 43 trials 32 / 21 / 26 / 5 💬 | 34 34 drugs [ 8 8 drugs ] | 3 3 genes 14 pathways | 212 (1) 約900人(自己免疫性PAP及び先天性PAP) (2) 212人 年齢分布 ![]() |
230 | 肺胞低換気症候群 [呼] 💬 "Alveolar hypoventilation syndrome", "AHS", "Hypoventilation syndrome", "Obesity hypoventilation syndrome", "OHS", "Congenital central hypoventilation syndrome", "CCHS", "Idiopathic central alveolar hypoventilation", "ICAH" "Alveolar hypoventilation syndrome", "AHS", "Hypoventilation syndrome", "Obesity hypoventilation syn ... | 8 8 trials 0 / 2 / 2 / 0 💬 | 11 11 drugs [ 5 5 drugs ] | 18 18 genes 28 pathways | 145 (1) 約3,000人 (2) 145人 年齢分布 ![]() |
231 | α1−アンチトリプシン欠乏症 [呼] 💬 "Alpha-1-antitrypsin deficiency", "AATD" | 89 89 trials 43 / 58 / 27 / 8 💬 | 89 89 drugs [ 16 16 drugs ] | 35 35 genes 47 pathways | 16 (1) 100人未満 (2) 16人 年齢分布 ![]() |